Document Detail

Acute and chronic antiarrhythmic efficacy of d-sotalol in patients with sustained ventricular tachyarrhythmias.
MedLine Citation:
PMID:  8293757     Owner:  NLM     Status:  MEDLINE    
To evaluate the clinical efficacy of d-sotalol, 84 patients with a history of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF), who had inducible sustained VT/VT at baseline electrophysiologic study (EPS), were investigated after intravenous (IV) d-sotalol (1.5-2.5 A total of 29 additional patients received only oral d-sotalol, (400-600 Acute success of antiarrhythmic therapy was defined as suppression of inducible sustained VT/VF. The overall success rate of IV d-sotalol was 38% (32/84) after a mean of 4.3 drugs failed to suppress inducibility. A 78% success rate (31/40) was demonstrated in patients who were also assessed after oral d-sotalol. Torsade de pointes type VT was seen in one patient. After 1 year, only 16% of patients with a positive EPS had a recurrence compared to 43% of patients with a negative EPS (P < 0.05). Estimated survival rates were 95 and 88% after 1 and 2 years of follow-up, respectively. Only five of 56 patients discontinued d-sotalol therapy because of adverse effects. IV d-sotalol appears to be an effective antiarrhythmic agent. Its long-term efficacy is predictable on the basis of therapy guided by electrophysiologic testing in patients with refractory ventricular tachyarrhythmias. The efficacy of d-sotalol seems comparable to that reported for d,l-sotalol.
J Brachmann; W Schöls; T Beyer; M Montero; B Enders; W Kübler
Related Documents :
20484827 - Relationship between oral amiodarone and inappropriate therapy from an implantable card...
21416547 - Functional outcomes related to the prevention of radiation-induced xerostomia: oral pil...
1721147 - Effect of antiarrhythmic drug therapy on the incidence of shocks in patients who receiv...
9408427 - Analysis of the treatment of spontaneous sustained stable ventricular tachycardia.
16181857 - Long-term effectiveness of total arch replacement for type a aortic dissection.
21149927 - Breath ammonia and trimethylamine allow real-time monitoring of haemodialysis efficacy.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European heart journal     Volume:  14 Suppl H     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1993 Nov 
Date Detail:
Created Date:  1994-03-03     Completed Date:  1994-03-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  85-7     Citation Subset:  IM    
Medical University Hospital, Department of Cardiology, Heidelberg, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardiac Pacing, Artificial
Follow-Up Studies
Middle Aged
Sotalol / administration & dosage,  chemistry,  therapeutic use*
Tachycardia, Ventricular / drug therapy*,  epidemiology
Time Factors
Ventricular Fibrillation / drug therapy*,  epidemiology
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachy...
Next Document:  Antiarrhythmic drugs and torsade de pointes.